Before a semaglutide appointment
Semaglutide treatment clinic
Before the visit,
get the questions clear.
Semaglutide works by copying a natural gut signal that helps manage blood sugar and hunger.
Start with the medicine
Then a next step.
Inside a semaglutide offer
Know what the offer means.
The US Food and Drug Administration is known as FDA; it reviews medicines for specific uses.
Semaglutide (Wegovy) is FDA-approved for weight management alongside changes in food and activity, as of September 26, 2026.
Get the product’s complete name and ask what form it comes in. Ask what it would treat in your case. Keep the answer in writing.
What does “compounded” mean?
Compounding makes a medicine for a particular patient, often when products already made cannot meet that person’s needs.
Compounded medicines lack FDA approval on September 26, 2026; FDA does not check their effects or quality, or assess their safety, before sale.
US law restricts routine copying of medicines already on the market, as of September 26, 2026. An exception requires the prescriber to decide that a change to the medicine would make an important difference to your care. A lower price alone does not qualify for that exception.
A patient who is allergic to a ready-made medicine’s dye may need a specially prepared version.
By September 26, 2026, FDA no longer listed semaglutide injections as being in short supply across the country. The extra time FDA allowed for making copies during that shortage had also ended.
If a clinic offers a compounded version, ask why you need it now.
The people behind it
Check the names behind the page.
Who would prescribe?
Get the clinician’s full name, job title and license number.
A state medical board licenses doctors and keeps public records of action it has taken against them.
A record showing no public action does not tell you how well that doctor cares for patients.
As of September 26, 2026, online clinicians need a license or other permission covering your physical location’s state when you meet.
Ask which board holds the record for that person’s profession. Use that board’s own search.
Which pharmacy would supply the medicine?
Before you pay, find out the pharmacy’s full name. For a compounded medicine, ask who would make it as well.
FDA’s pharmacy lookup leads to state license records.
A listing confirms that a license exists; it does not judge the pharmacy’s work.
Match the name in the record to the name you were given.
Who answers your questions once the visit is over?
Find out how to contact a clinician, when follow-up takes place and how the service arranges an in-person exam if needed.
Telehealth connects you with a clinician in another place, using video, telephone calls or online messages.
The national organization representing state medical boards says the standard of care applies equally to online and in-person visits.
As of September 26, 2026, this is advice for state boards; the rules for your online visit come from your state.
Ask the board serving the state you will occupy at appointment time which rules apply.
Your history at the visit
Bring your history.
Ask about the hard parts.
The official semaglutide medicine information, called the label, lists health problems to discuss before treatment, including serious stomach trouble.
Tell the clinician about gallbladder trouble, such as gallstones, and pancreas inflammation, which means painful swelling that can cause severe belly pain.
Tell the clinician about thyroid cancer in your family. Thyroid tumors are growths that may cause a lump in the neck or trouble swallowing.
Tell the clinician about any eye damage from diabetes, all diabetes medicines you take, any pregnancy plans and any surgery coming up.
Bring a list of medicines and supplements. Write down what you hope treatment would change. Ask which tests, if any, would help decide.
What may go wrong?
In Wegovy injection weight-loss trials, common problems included vomiting, feeling sick, loose stools and difficulty passing stools.
The medicine information warns about gallstones and painful swelling of the pancreas. It also warns that vomiting or loose stools can cause enough fluid loss to harm the kidneys. Pancreas trouble may cause belly pain that lasts or is severe and may spread into your back.
The strongest alert
The medicine information’s strongest alert is called a “boxed warning.” Semaglutide caused thyroid tumors in rats and mice; whether it causes them in people is unknown.
When semaglutide must not be used
The medicine information says semaglutide must not be used if you or your family have had medullary thyroid cancer, a rare kind. It also rules out semaglutide for MEN 2, a rare condition passed from parent to child and listed with the thyroid cancer warning.
If either name is unfamiliar, ask the clinician to help check your own and your family’s medical records.
Semaglutide is also ruled out if you have had a serious allergic reaction to it or another ingredient in the medicine.
Ask: “Which of these matters for me? Who can help if a problem starts?”
Keep these to hand
A short reading list for your checks.
- Find a medical board
The Federation of State Medical Boards points to each board. Use the right board for the doctor’s license and public record.
- Find the pharmacy license search
FDA links to the state records. Start with the full pharmacy name from the service you are checking.
- Read the official semaglutide (Wegovy) medicine information
The National Library of Medicine hosts this full document. Use the patient information near the end to prepare for a care visit.
- Read FDA’s concerns about compounded weight medicines
FDA’s reports, as of September 26, 2026, describe people measuring compounded semaglutide incorrectly; some cases required hospital care. FDA also describes fake products, sometimes naming a pharmacy that does not exist.